No Data
Novo Nordisk Shares Higher on White House Plans to Extend Obesity Drug Coverage -- Market Talk
White House Proposes Big Expansion of Medicare, Medicaid Coverage of Obesity Drugs
Drug Compounders Fight Drugmaker Efforts to Push Them Out of Market for GLP-1 Medications
Trump's Made His Health Picks. What They Mean for the Sector. -- Barrons.com
Hims & Hers up 18% Amid Optimism for Compounders With Makary FDA Pick
Novo Nordisk Foundation Targets US, Europe After Obesity Boost
loading...